Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1999
11/25/1999WO1999043815A3 Human monoclonal antibodies capable of oligospecifically recognizing the major tumor-associated gangliosides and methods of use thereof
11/25/1999WO1999043808A8 Human c-maf compositions and methods of use thereof
11/25/1999WO1999042834A3 Treating cancer
11/25/1999WO1999040881A3 Specific antibodies against mammary tumor-associated mucin, method for production and use
11/25/1999WO1999040199A3 A novel fungal protein critical for expression of fungal proteins
11/25/1999WO1999038976A3 Human growth factor homologs
11/25/1999DE19806803A1 Transporter für Saccharid-gekoppelte Zytostatika in Tumorzellen Transportation for saccharide-linked cytotoxic agents in tumor cells
11/25/1999CA2332507A1 Angiostatin receptor
11/25/1999CA2332331A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
11/25/1999CA2331917A1 Novel method for gene cloning
11/25/1999CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999CA2329153A1 Novel g-protein coupled receptor
11/25/1999CA2329139A1 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999CA2328986A1 Gene recombinant antibodies
11/25/1999CA2328893A1 Vegf activity inhibitors
11/25/1999CA2328527A1 Secreted proteins
11/25/1999CA2328510A1 Human nucleic acid methylases
11/25/1999CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999CA2328501A1 Prevention and treatment of hypergastrinemia
11/25/1999CA2328496A1 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999CA2328486A1 Osteoporosis treatment
11/25/1999CA2326700A1 Enzymatically-active recombinant human .beta.-tryptase and method of making same
11/25/1999CA2325600A1 Methods for amyloid removal using anti-amyloid antibodies
11/24/1999EP0959355A1 Reagents for the detection and quantification of thryoxine in fluid samples
11/24/1999EP0959129A1 Drugs for treating exocrine gland disorders and transgenic mice to be used for screening the same
11/24/1999EP0958382A2 Novel method for testing the differentiation status in pancreatic cells of a mammal
11/24/1999EP0958374A1 T1 receptor-like ligand i
11/24/1999EP0958366A1 Human chemokine beta-13
11/24/1999EP0958365A1 Granulocyte chemotactic protein 2 variant
11/24/1999EP0958364A1 Immunotherapy and improved vaccines
11/24/1999EP0958363A1 Human regulator of g-protein signaling - (hrgs)
11/24/1999EP0958362A1 Isolation and use of motoneuronotrophic factors
11/24/1999EP0958359A1 Protein inhibitor of neuronal nitric oxide synthase
11/24/1999EP0958304A1 Nucleotide sequence encoding the cd33-like protein
11/24/1999EP0957937A1 VACCINES, ANTIBODIES, PROTEINS, GLYCOPROTEINS, DNAS AND RNAS FOR PROPHYLAXIS AND TREATMENT OF $i(CRYPTOSPORIDIUM PARVUM) INFECTIONS
11/24/1999EP0833653A4 Serum immunoregulatory polypeptides and uses therefor
11/24/1999CN1236393A Chitinase materials and methods
11/24/1999CN1235848A Pigment labelled protein composite and its preparing method
11/24/1999CN1046737C Antibodies against allogenic and xenogenic proteins, their use in diagnosis and therapy and methods for determination thereof
11/24/1999CN1046635C Composition and mether using nitrooxides to avoid oxygen toxicity
11/23/1999US5990383 Plant transformed with nucleotide sequence which encodes a vegetative insecticidal protein from bacillus species
11/23/1999US5990297 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
11/23/1999US5990296 Improving binding affinity of single chain lewis-y antibodies by replacing amino acid at position 95 with serine; immunotoxins for anticarcinogenic/antitumor agents
11/23/1999US5990287 Immunoglobulin which binds to surface antigen of stomach cancer cell mnk45 and colon cancer cell c-1; for diagnosis of cancer; for anticarcinogenic agents and immunotoxins
11/23/1999US5990286 Antibodies with reduced net positive charge
11/23/1999US5990285 Catalytic antibodies against cocaine
11/23/1999US5990282 Receptor protein for human B cell stimulatory factor-2
11/23/1999US5990275 Linker and linked fusion polypeptides
11/23/1999US5990274 Cyclosporine derivatives and uses thereof
11/23/1999US5989925 Antibody to and assay for peptide linked-pyridinoline as indicator of bone resorption level
11/23/1999US5989907 Methods and compositions for calcium binding proteolipid encoding nucleic acids
11/23/1999US5989884 Polypeptides of the histidyl transfer rna synthetase family; for screening of antibiotics, bactericides, and bacteristats for treatment and prevention of clamydial infections; diagnosis
11/23/1999US5989883 Amino acid sequence of human polypeptide; for treatment of cachexia and alzheimer's disease; anticarcinogenic agents
11/23/1999US5989881 Gene therapy, expression and engineering
11/23/1999US5989866 FGF homologs
11/23/1999US5989864 DNA encoding spo-rel polypeptides
11/23/1999US5989863 Human ankyrin family protein
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989856 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
11/23/1999US5989848 Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis
11/23/1999US5989843 Measuring labeled phosphate
11/23/1999US5989841 Testing foods; contacting with antibodies; detecting immunological complex
11/23/1999US5989838 Immunological methods of detecting MN proteins and MN polypeptides
11/23/1999US5989836 Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)
11/23/1999US5989834 Contacting nonneuronal cells transfected with vector; gene expression
11/23/1999US5989830 Bifunctional or bivalent antibody fragment analogue
11/23/1999US5989829 Autoantibodies and their targets in the diagnosis of peripheral neuropathies
11/23/1999US5989828 Binding to matrix; vaccines
11/23/1999US5989826 Detecting cancer; biochemical immobilization; complexing; evaluating cytotoxicity
11/23/1999US5989822 Diagnosis and treatment of cancer, neurodegenerative and autoimmune diseases; gene expression
11/23/1999US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
11/23/1999US5989584 CCK antibodies used to improve feed efficiency
11/23/1999US5989563 Viral agent associated with mystery swine disease
11/23/1999US5989561 Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
11/23/1999US5989554 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
11/23/1999US5989553 Expression library immunization
11/23/1999US5989550 Materials and methods for immunocontraception
11/23/1999US5989547 Leptospiral outer membrane proteins
11/23/1999US5989537 Methods for stimulating granulocyte/macrophage lineage using thrombopoietin
11/23/1999CA2025929C Method for protein binding enzyme complementation assays
11/23/1999CA1340827C Diagnostic methods for detecting lymphomas in humans
11/22/1999CA2238217A1 4e-bp3, a new member of the eukaryotic initiation factor 4e-binding protein family and use thereof
11/19/1999CA2237915A1 Osteoporosis treatment
11/18/1999WO1999058981A2 Diagnostic tests for alzheimer's disease
11/18/1999WO1999058980A1 HUMAN CHROMOGRANIN A (GgA) IMMUNOLOGIC ASSAY, ANTIBODIES, REAGENTS AND KITS FOR SAID ASSAY
11/18/1999WO1999058692A2 Human apoptosis associated proteins
11/18/1999WO1999058684A2 Compounds from moraxella catarrhalis
11/18/1999WO1999058683A2 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
11/18/1999WO1999058681A2 Transgenic plant cells expressing a recombinant plant e2f peptide
11/18/1999WO1999058680A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor
11/18/1999WO1999058679A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses
11/18/1999WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
11/18/1999WO1999058676A2 Semaphorin polypeptides
11/18/1999WO1999058675A2 Human genes and gene expression products v
11/18/1999WO1999058667A1 Rhotekin, a putative target for rho
11/18/1999WO1999058661A1 Continuous in vitro evolution
11/18/1999WO1999058660A1 97 human secreted proteins
11/18/1999WO1999058641A2 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors
11/18/1999WO1999058573A1 Diagnosis and treatment of hepatic disorders
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis